Cadila Healthcare inks pact to extend tenure of JV with Bayer
New Delhi: Drug firm Cadila Healthcare on Wednesday said it has inked a pact to extend the tenure of a joint venture with Bayer Pte ltd for two months to explore possibilities of further collaboration.
The company has signed an agreement to extend the tenure of the joint venture with a Bayer Group firm for a period of two months, Cadila Healthcare said in a regulatory filing.
Read also: Cadila Healthcare eyes doubling Covid-19 vaccine capacity amid record India surge: Bloomberg
The companies had entered into an agreement on January 28, 2011 for the joint venture, pursuant to which a company was formed to carry on with the business of marketing of pharmaceutical products, it added.
Read also: Zydus Cadila gets DCGI nod to moderate Covid-19 drug Virafin
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd